Bowen Ke

3.5k total citations · 1 hit paper
100 papers, 2.5k citations indexed

About

Bowen Ke is a scholar working on Molecular Biology, Biomedical Engineering and Pharmacology. According to data from OpenAlex, Bowen Ke has authored 100 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 22 papers in Biomedical Engineering and 14 papers in Pharmacology. Recurrent topics in Bowen Ke's work include Advanced biosensing and bioanalysis techniques (13 papers), Nanoplatforms for cancer theranostics (12 papers) and Cannabis and Cannabinoid Research (10 papers). Bowen Ke is often cited by papers focused on Advanced biosensing and bioanalysis techniques (13 papers), Nanoplatforms for cancer theranostics (12 papers) and Cannabis and Cannabinoid Research (10 papers). Bowen Ke collaborates with scholars based in China, United States and Germany. Bowen Ke's co-authors include Binghe Wang, Xingyue Ji, Zhixiang Pan, Yueqin Zheng, Gu He, Bingchen Yu, Minyong Li, Ladie Kimberly De La Cruz, Yong Qin and Mao Tian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Bowen Ke

96 papers receiving 2.5k citations

Hit Papers

Biosensors for rapid detection of bacterial pathogens in ... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bowen Ke China 29 1.2k 738 531 370 243 100 2.5k
Frank Sinner Austria 32 1.2k 1.0× 584 0.8× 400 0.8× 131 0.4× 338 1.4× 91 3.4k
Kazumi Sasamoto Japan 18 1.3k 1.1× 355 0.5× 338 0.6× 319 0.9× 226 0.9× 49 3.3k
Yueqin Zheng United States 21 945 0.8× 363 0.5× 638 1.2× 233 0.6× 119 0.5× 38 1.9k
Barbara Rolando Italy 28 687 0.6× 337 0.5× 609 1.1× 221 0.6× 81 0.3× 105 2.1k
Xiaokang Li China 25 741 0.6× 308 0.4× 276 0.5× 325 0.9× 229 0.9× 89 1.8k
Soon‐Sun Hong South Korea 35 1.8k 1.5× 398 0.5× 365 0.7× 255 0.7× 62 0.3× 120 3.6k
Yun Deng China 29 856 0.7× 283 0.4× 331 0.6× 173 0.5× 199 0.8× 123 2.4k
Xinming Li China 24 1.4k 1.1× 227 0.3× 409 0.8× 126 0.3× 126 0.5× 78 2.3k
Toshiyasu Sakane Japan 38 1.2k 1.0× 323 0.4× 221 0.4× 212 0.6× 141 0.6× 143 4.5k

Countries citing papers authored by Bowen Ke

Since Specialization
Citations

This map shows the geographic impact of Bowen Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowen Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowen Ke more than expected).

Fields of papers citing papers by Bowen Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bowen Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowen Ke. The network helps show where Bowen Ke may publish in the future.

Co-authorship network of co-authors of Bowen Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Bowen Ke. A scholar is included among the top collaborators of Bowen Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bowen Ke. Bowen Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yuyu, Wei Yan, Hongyue Ma, et al.. (2025). Celastrol directly targets LRP1 to inhibit fibroblast-macrophage crosstalk and ameliorates psoriasis progression. Acta Pharmaceutica Sinica B. 15(2). 876–891. 2 indexed citations
2.
Song, Jie, Yanan Zhang, Wenwen Chen, et al.. (2025). Genetic variants associated with chronic postsurgical pain: evidence from the China Surgery and Anaesthesia Cohort study. British Journal of Anaesthesia. 135(5). 1257–1268.
3.
Zhang, Kai, Yueyang Wang, Linyu Yu, et al.. (2025). LigDockTailor: Ligand-specific docking tool matching using multidimensional descriptors. Computational Biology and Chemistry. 119. 108554–108554.
4.
Xiang, Pan, Bin Guo, Su Lui, et al.. (2025). Rapid amyloid-β clearance and cognitive recovery through multivalent modulation of blood–brain barrier transport. Signal Transduction and Targeted Therapy. 10(1). 331–331. 2 indexed citations
5.
Fu, Lin, Chen Chen, Yong Qin, et al.. (2024). Design, synthesis, and biological evaluation of new bis-benzylisoquinoline-based analogues as potential neuromuscular blocking agents. Bioorganic & Medicinal Chemistry Letters. 108. 129793–129793. 1 indexed citations
6.
Qiu, J. F., Wencheng Liu, Meiyuan Chen, et al.. (2024). Identification of N-(((1S,3R,5S)-adamantan-1-yl)methyl)-3-((4-chlorophenyl)sulfonyl)benzenesulfonamide as novel Nav1.8 inhibitor with analgesic profile. Bioorganic & Medicinal Chemistry Letters. 110. 129862–129862.
7.
Liu, Xianggen, et al.. (2024). Anesthetic drug discovery with computer-aided drug design and machine learning. SHILAP Revista de lepidopterología. 2(1). 11 indexed citations
8.
Wang, Yanfang, et al.. (2024). Discovery of a novel series of pyridone amides as NaV1.8 inhibitors. Bioorganic & Medicinal Chemistry Letters. 101. 129655–129655. 3 indexed citations
9.
Cheng, Lin, Zhuang Miao, Zhe Li, et al.. (2024). Cryo-EM structure of small-molecule agonist bound delta opioid receptor-Gi complex enables discovery of biased compound. Nature Communications. 15(1). 8284–8284. 7 indexed citations
10.
Zhang, Minjie, Peng Cui, Kai Zhang, et al.. (2023). Asymmetric hydrogenation of all-carbon tetrasubstituted α-acylpyrazole-β-alkyl cycloalkenes. Organic Chemistry Frontiers. 10(20). 5070–5075. 6 indexed citations
11.
Li, Ziyuan, et al.. (2023). Camphor Attenuates Hyperalgesia in Neuropathic Pain Models in Mice. Journal of Pain Research. Volume 16. 785–795. 14 indexed citations
13.
Yu, Bingchen, et al.. (2022). Prodrugs of Persulfide and Sulfide: Is There a Pharmacological Difference between the Two in the Context of Rapid Exchanges among Various Sulfur Species In Vivo ?. Angewandte Chemie International Edition. 61(20). e202201668–e202201668. 17 indexed citations
14.
Yin, Qinqin, Weiyi Zhang, Bowen Ke, Jin Liu, & Wensheng Zhang. (2021). Lido-OH, a Hydroxyl Derivative of Lidocaine, Produced a Similar Local Anesthesia Profile as Lidocaine With Reduced Systemic Toxicities. Frontiers in Pharmacology. 12. 678437–678437. 2 indexed citations
15.
Chen, Xinxin, Xiaojun Qin, Gaopan Dong, et al.. (2021). A bioluminescent probe for in vivo imaging of pyroglutamate aminopeptidase in a mouse model of inflammation. Bioorganic & Medicinal Chemistry Letters. 43. 128049–128049. 8 indexed citations
16.
Gou, Shuangquan, Jun Yang, Ya Ma, et al.. (2020). Multi-responsive nanococktails with programmable targeting capacity for imaging-guided mitochondrial phototherapy combined with chemotherapy. Journal of Controlled Release. 327. 371–383. 37 indexed citations
17.
Zhang, Xueqing, Yamei Huang, Heliang Song, et al.. (2020). Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics. Journal of Controlled Release. 328. 454–469. 37 indexed citations
18.
Gong, Deying, Jun Yang, Bowen Ke, et al.. (2020). New insights for screening etomidate analogues in the human H295R cell model. Toxicology in Vitro. 68. 104934–104934. 2 indexed citations
19.
Wang, Qi, Qinqin Yin, Jun Yang, et al.. (2017). Evaluation of the cardiotoxicity and resuscitation of rats of a newly developed mixture of a QX-314 analog and levobupivacaine. Journal of Pain Research. Volume 10. 737–746. 5 indexed citations
20.
Ke, Bowen, Yong Qin, Fengyan Zhao, & Yi Qu. (2008). Synthesis and biological evaluation of novel 3′-N-tert-butylsulfonyl analogues of docetaxel. Bioorganic & Medicinal Chemistry Letters. 18(17). 4783–4785. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026